Related by context. All words. (Click for frequent words.) 85 Submits NDA 85 Receives Orphan Drug Designation 83 Mylan Receives Approval 83 Completes Patient Enrollment 83 Files IND 83 Receives Approvable Letter 82 Files Investigational 82 Drug Candidate 82 Submits Supplemental 81 Meets Primary Endpoint 81 Generic Version 81 NDA Submission 81 Investigational Compound 81 Patient Enrollment 81 Phase 2b Clinical Trial 81 IND Application 81 Granted Orphan Drug 81 Phase IIb Trial 80 Completes Enrollment 80 Phase IIb Clinical Trial 80 Presents Positive 80 Announces Tentative Approval 80 Taro Receives 80 FDA Clears 80 Initiates Clinical Trial 80 Initiates Phase II 80 Prostate Cancer Vaccine 80 Receives Complete Response 80 Supplemental Biologics License Application 80 Initiates Phase III 79 Expanded Indication 79 FDA Approvals 79 Fast Track Status 79 Psoriasis Drug 79 Submits Biologics License Application 79 Phase III Clinical Trial 79 Generic Version Of 79 Phase 2b Trial 79 Schizophrenia Drug 79 Osteoporosis Drug 79 FDA Okays 79 Presents Preclinical Data 78 Oral Calcitonin 78 Clinical Trial Results 78 Initiates Enrollment 78 Generic Versions 78 Drug Fails 78 Phase 2a Trial 78 Arthritis Drug 78 Initiate Phase III 78 Phase III Trial 78 Phase 1b Clinical Trial 78 Pivotal Phase III 77 Demonstrates Positive 77 Gout Drug 77 Receives Milestone Payment 77 FDA Approves 77 Initiates Clinical 77 Inhaled Insulin 77 Migraine Drug 77 Receives Positive Opinion 77 Investigational Treatment 77 Improves Survival 77 Receives Orphan Drug 77 Preclinical Data 77 Receives Fast Track 77 Resubmission 77 Vaccine Adjuvant 77 PDUFA Date 77 Receives Tentative Approval 77 Demonstrates Significant 77 Receives Tentative FDA 77 Teva Provides Update 77 Initiate Clinical Trial 76 Positive Opinion 76 Gets FDA Clearance 76 Study Evaluating 76 Advanced Melanoma 76 Epilepsy Drug 76 Rheumatoid Arthritis Drug 76 Single Dose 76 IND Filing 76 Initiate Phase 76 Receives FDA Clearance 76 Lung Cancer Drug 76 Pivotal Study 76 PRN FDA Approves 76 Launches Generic Version 76 Clinical Trial Evaluating 76 Vitrasert R 76 Lupus Drug 76 Tezampanel 76 Patients Treated With 76 Cholesterol Lowering Drug 76 Confirmatory Phase 76 Prolongs Survival 76 Adjuvant Treatment 75 Phase IIa Clinical Trial 75 Novel Antibiotic 75 Cholesterol Drug 75 Therapeutic Competitors Companies 75 Submits Response 75 Initiates Phase 75 FDA Approval 75 Begins Dosing 75 BioSante Pharmaceuticals Announces 75 Receive Milestone Payment 75 Initiates Clinical Trials 75 ANDA Filing 75 Dose Ranging Study 75 Submits IND 75 Pivotal Phase 75 Trial Evaluating 75 Successfully Completes Phase 75 Investigational Oral 75 Transdermal Patch 75 Investigational Drug 75 Investigational Agent 75 Weight Loss Drug 75 Previously Treated 74 FDA Clearance 74 Effectively Treats 74 Blood Pressure Drug 74 Milestone Payment From 74 Earns Milestone Payment 74 Initiates Dosing 74 Recommends Approval 74 Receives CE Marking 74 Drug Shows Promise 74 Intravenous Formulation 74 Announces FDA Clearance 74 pralatrexate injection folate analogue 74 First Patient Enrolled 74 Biologic License Application 74 JAK2 Inhibitor 74 Present Preclinical Data 74 Combination Treatment 74 Anti Nausea 74 Pivotal Trial 74 Shows Promising 74 Novel Oral 74 Grants Orphan Drug 74 First Patient Treated 74 Protease Inhibitor 74 Sagent Pharmaceuticals Announces 74 Complicated Skin 74 Aztreonam Lysine 74 Testosterone Gel 74 Humanized Anti 74 FDA Approvable Letter 74 Extended Release 74 Begin Clinical Trials 74 Initiates Phase 2b 74 Announce License Agreement 73 Immunomedics Announces 73 Cervical Cancer Vaccine 73 Unanimously Recommends Approval 73 Achieves Primary Endpoint 73 Submits Application 73 Enrolls First 73 Study Showed 73 Phase 2a Clinical Trial 73 Demonstrates Potent 73 Submits Investigational 73 Orphan Status 73 Long Term Efficacy 73 Licenses Novel 73 Shows Promise Against 73 Release Capsules 73 JAK Inhibitor 73 methylnaltrexone bromide 73 Commences Phase 73 Romiplostim 73 Rotavirus Vaccine 73 FDA APPROVES 73 Demonstrates Potential 73 Develop Novel 73 Severe Sepsis 73 Demonstrates Efficacy 73 HCV Protease Inhibitor 73 Milestone Payment 73 Recombinant Human 73 Million Milestone Payment 73 Pharmacokinetic Study 73 FDA Panel Recommends 73 Combination REOLYSIN R 73 Therapeutic Vaccine 73 Glatiramer Acetate 73 Demonstrates Sustained 73 Seasonal Influenza Vaccine 73 Bazedoxifene 73 Blood Thinner 73 sapropterin dihydrochloride 73 Pafuramidine 73 Issues Complete Response 73 Anemia Drug 73 Systemic Delivery 73 Anti Tumor 73 Crofelemer budesonide foam 73 Adjunctive Therapy 73 Generic Lovenox 73 Hsp# Inhibitor 73 Oral Fingolimod 73 Medoxomil 73 Shows Efficacy 73 R lenalidomide 72 Significantly Improved 72 Marketing Authorisation Application 72 Patient Enrolment 72 Anticancer Activity 72 VIVUS Announces 72 Low Dose 72 Phase 2b Study 72 Data Suggest 72 markets COLAZAL 72 Topical Treatment 72 Phase III Trials 72 Obtains FDA 72 balsalazide disodium Capsules 72 Vaccine Protects Against 72 markets HP Acthar 72 Hydrochlorothiazide Tablets 72 gets USFDA nod 72 Receives Positive 72 Generic Protonix 72 Refractory Hodgkin Lymphoma 72 Kuvan R 72 Announces Initiation 72 Newly Diagnosed Multiple Myeloma 72 Patent Covering 72 Improves Outcomes 72 Sign Licensing Agreement 72 include Phenoptin TM 72 Bosutinib 72 Postmenopausal Osteoporosis 72 Hormone Refractory Prostate Cancer 72 Clinical Trial Data 72 Mg Usa 72 Peginterferon alfa 2b 72 Combo Therapy 72 Shingles Vaccine 72 Nicotine Vaccine 72 Dose Escalation 72 Hematological Malignancies 72 Antitumor Activity 72 Acute Attacks 72 Nasdaq VNDA 72 Milestone Payments 72 Pooled Analysis 72 Therapeutic Competitors companiesandmarkets.com adEgemonye 72 submitted Biologics License 72 Oral Formulation 72 FOLOTYN ® 72 Pegloticase 72 Resubmits 72 AVI BioPharma Announces 72 Romidepsin 72 Receives Marketing Authorization 72 Drug Resistant 72 Metastatic Melanoma 72 Osteoporosis Treatment 71 Pivotal Phase II 71 VIVITROL ® 71 Idenix Novartis 71 Resistant Hypertension 71 Vicriviroc 71 Collaborators Present 71 II Clinical Trial 71 STERIS Corporation Announces 71 Node Positive 71 Efficacy Results 71 Inc Therapeutic Competitors 71 Plaque Psoriasis 71 Molecular Diagnostic Test 71 novel orally inhaled 71 Transdermal System 71 Febuxostat 71 Completes Dosing 71 Presents Preclinical 71 Kinase Inhibitor 71 Xcytrin R 71 Treatment Naïve 71 NexMed Receives 71 Drug Combo 71 Premarket Approval Application 71 Hepatitis B Vaccine 71 Reports Preclinical Data 71 Announce Collaboration Agreement 71 Spectrum Pharmaceuticals Announces 71 Extended Release Capsules 71 Fungal Infections 71 Liprotamase 71 Mg Uk 71 FDA Approves Generic 71 Alvine Pharmaceuticals 71 Demonstrated Significant 71 STELARA TM 71 Reveals Positive 71 Commence Phase 71 vapreotide acetate 71 Epilepsy Drugs 71 Expedited Review 71 Anti Inflammatory 71 Novel Inhibitor 71 Personalized Immunotherapy 71 Survival Benefit 71 Horizant ™ 71 First Patient Dosed 71 Myeloma Patients 71 RNAi Therapeutics 71 Shows Promise 71 Desvenlafaxine 71 Significantly Reduced 71 Haemophilus b Conjugate 71 corticotropin injection 71 Treatment Resistant 71 Fentanyl Patch 71 Treated Patients 71 Smallpox Vaccine 71 Anticancer Agent 71 By JAMAAL ABDUL 71 Schizophrenia Treatment 71 Prospective Randomized 71 Delayed Release 71 HER2 Positive 71 Migraine Treatment 71 Receptor Agonist 71 Kuvan TM sapropterin 71 ODT metoclopramide HCl PEPCID 71 Shows Statistically Significant 71 Therapeutic Antibody 71 Brentuximab Vedotin SGN 71 Tyrosine Kinase Inhibitor 71 SPRYCEL ® 70 Renal Cell Carcinoma 70 Receives Favorable 70 Prostate Cancer Patients 70 Double Blind Placebo 70 Controlled Study 70 Flamel Technologies Announces 70 Eszopiclone 70 Acne Drug 70 Ondansetron Orally Disintegrating Tablets 70 Tesamorelin 70 ® decitabine 70 Fixed Dose 70 COLAZAL ® 70 TO AVOID PREGNANCY WHILE 70 Anticancer Drug 70 Adjuvant Chemotherapy 70 Tentative Approval 70 Potent Antiviral Activity 70 BioElectronics Announces 70 BRILINTA 70 Second Pivotal Phase 70 R memantine HCl 70 Melphalan 70 SABER ™ 70 Receives Patent 70 Anticancer Compound 70 Biogen Genentech 70 Treating Chronic 70 Announces Publication 70 Disease Modifying 70 Antibody Drug Conjugate 70 Lanthanum Carbonate 70 Abstract Accepted 70 Novel Mechanism 70 highly purified pasteurized 70 Dementia Related Psychosis 70 Gets Tentative 70 Antiviral Drugs 70 Inhalation Aerosol 70 Hematological Cancers 70 Anti Inflammatory Drug 70 TRANSDUR ™ 70 Ebola Vaccine 70 Metformin HCl 70 Polymerase Inhibitor 70 R Saizen R 70 Significantly Improves 70 Namenda Memantine HCl 70 Versus Placebo 70 IG HCR ;) CO 70 Vitrasert ® 70 TNF Blockers 70 Announces Poster Presentations 70 Lowers Risk 70 Sangamo BioSciences Announces 70 Calcium Acetate 70 topical gel formulation 70 Reduces Risk 70 Risperidone Oral Solution 70 Beta Blocker 70 Unsolicited Proposal From 70 Preliminary Injunction Against 70 Desvenlafaxine Succinate 70 Therapy Improves 70 liver resection surgeries 70 Enlarged Prostate 70 Paliperidone Palmitate 70 Lamotrigine Tablets 70 novel emulsion formulation 70 Immunosuppressant 70 Anti Tumor Activity 70 Drug Maker 70 Well Tolerated 70 Study Demonstrates 70 Significantly Reduces 70 Slow Progression 70 Novel Compound 70 Kidney Transplant Patients 70 Patients Receiving 70 Pivotal Clinical Trial 70 RNAi Therapeutic 70 Patients Treated 70 Maleate 70 Statistically Significant 70 HCl Injection 70 Boxed Warnings 70 Hypertensive Patients 70 Heartburn Drugs 70 Clinical Study Shows 70 Plus Ribavirin 70 Antitumor 70 Infected Patients 70 Improved Survival 70 TRANSDUR ® 70 R bisoprolol Euthyrox 70 DOR BioPharma Announces 70 Receives NASDAQ 70 Sign License Agreement 70 Reacquires 70 Slows Progression 70 Oral Cladribine 70 Maribavir 70 Agonist MABA program 70 Oral Spray 70 Inhaled Corticosteroids 70 Genetically Modified Salmon 70 Orally Active 70 GRAS Status 70 Presents Positive Preclinical 70 OMAPRO ™ 70 nasal calcitonin product 70 Monoclonal Antibody 70 Chronic Hepatitis C 70 Preclinical Study 70 Unanimously Recommends 70 Vaccine Candidate 70 Pandemic Influenza Vaccine 69 Influenza Vaccine 69 Rheumatoid Arthritis Patients 69 Therapeutic Competitors Report 69 Multiple Ascending Dose 69 Nasal Powder 69 Companion Diagnostic 69 Fixed Dose Combination 69 Myelodysplastic Syndromes 69 ELADUR TM 69 R famotidine 69 Randomized Phase II 69 Proven Effective 69 Pivotal Trials 69 Clinical Study 69 Levoleucovorin 69 Appears Safe 69 Sapacitabine 69 Orphan Designation 69 Revises FY# Outlook 69 Optimer Pharma 69 dihydrochloride Tablets 69 Hemispherx flagship products 69 Small Molecule 69 Immunotherapeutic 69 Therapeutic Potential 69 Treatment Experienced 69 particularly SANCTURA XR 69 Diabetic Nephropathy 69 R metformin Concor 69 Showed Significant 69 refractory chronic lymphocytic 69 Nuvelo Announces 69 Recurrent Glioblastoma 69 Diabetic Neuropathy 69 Staphylococcus aureus Immune Globulin 69 Clinical Efficacy 69 Crit Rev 69 Aloxi ® 69 Bepreve TM 69 non nucleoside inhibitor 69 Pazopanib 69 Attenuates 69 Therapeutic Efficacy 69 NicVAX TM 69 Metabolic Disorder 69 Stronger Warnings 69 ® adefovir dipivoxil 69 Unsolicited Tender Offer 69 Announce Initiation 69 Cutaneous T 69 GATTEX TM 69 Testosterone Patch 69 Telik logo TELINTRA 69 Mycophenolate Mofetil 69 RANK Ligand inhibitor 69 topically applied SEPA 69 Tumor Targeting 69 Announce Merger Agreement 69 MEK Inhibitor 69 Fondaparinux 69 Advanced Prostate Cancer 69 Statin Drugs 69 SPL# Gel vaginal microbicide 69 Treatment Reduces 69 HER2 Positive Breast Cancer 69 Gene Variant 69 Relapsing Multiple Sclerosis 69 NOTE POSIDUR ™ 69 Demonstrates Statistically Significant 69 Treatment Naive Patients 69 Anti Clotting Drug 69 Approvable 69 Aflibercept 69 microRNA Therapeutics 69 Employment Inducement Awards 69 Diamyd Medical Diamyd 69 Treatment Shows Promise 69 CysDisplay R 69 Genetically Engineered Salmon 69 Weight Loss Pill 69 Multiple Myeloma Patients 69 Diabetic Foot Ulcer 69 Treat Anemia 69 Terminate Merger Agreement 69 Unigene nasal calcitonin 69 Novel Anti Inflammatory 69 Phase III Pivotal 69 Monotherapy 69 VISICOL R 69 acetonide FA 69 CHEAP ONLINE PHARMACY LOW 69 Previously Untreated 69 oral prodrug 69 Phase IIa Trial 69 IN PATIENTS WITH 69 Diet Pill 69 Anidulafungin 69 oropharyngeal candidiasis OPC 69 See CLINICAL PHARMACOLOGY 69 Pharmacokinetics PK 69 Clinical Trial Enrollment 69 Enteral Feed Devices 69 Oxybutynin 69 Peginterferon Alfa 2a 69 dependent kinase inhibitor 69 mesylate tablets approved 69 Receives Conditional 69 Inhibits 69 INSPIRE Trial Phase III 69 Neuroendocrine Tumors 69 Sustained Release 69 Silicone Breast Implants 69 Receives CE 69 submitted supplemental Biologics 69 Settle Patent Litigation 69 Unfractionated Heparin 69 IIa Clinical Trial 69 Lupus Nephritis 69 Application MAA 69 Drug Coated Stent 69 Ustekinumab 69 Anemia Drugs 69 PDL BioPharma Announces 69 ARIXTRA R 69 MKC# MKC# PP 69 XL# anticancer compounds 69 Genotyping Test 69 Lifts FY# Outlook 69 Nasdaq Deficiency Notice 69 Vildagliptin 69 Randomized Double Blind 69 Vioxx Successor 69 markets XIFAXAN ® 69 Confirms Efficacy 69 please visit www.abraxane.com 69 Transcept Pharmaceuticals 69 Antifungal 69 virus HCV protease inhibitor 69 PROVENGE ® 69 k Clearance 69 Zorbtive TM 69 Combination Therapy 69 COLAZAL R 69 By JENNIFER LEARN 69 Pandemic Flu Vaccine 69 Erectile Dysfunction Drug 69 Oral Solution 69 platform HDL Mimetic 69 Drug Eluting Stent System 69 Pneumococcal Vaccine 69 Announces Positive 69 J Am Coll 69 Colorectal Cancer Patients 69 Aeolus Pharmaceuticals Announces 69 Announce Licensing Agreement 69 SYCREST 69 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 69 GTC recombinant form 69 Mouse Model 69 ELADUR ™ 69 CRM# Protein 69 hypereosinophilic syndrome 69 Advanced Colorectal Cancer 68 Topical Gel 68 Fast Tracked 68 Augment ™ 68 Integrase Inhibitor 68 Breast Cancer Recurrence 68 candidates Azedra TM 68 Randomized Clinical Trial 68 Awarded Qualifying Therapeutic 68 Antiviral Drug 68 PROMUS R 68 therefore therapeutically equivalent 68 Antigen Specific 68 Adenoma 68 Orapred ODT 68 NICE Recommends 68 Patent Infringement Litigation 68 Telik Announces 68 HDAC Inhibitor 68 Commercialize Novel 68 Topline Results 68 diarrhea fatigue asthenia 68 Civacir TM Hepatitis C 68 Efficacy Trial 68 humanized therapeutic 68 Civacir 68 Atypical Antipsychotic 68 Sumatriptan Succinate 68 Chemotherapy Regimen 68 Viagra Soft Cialis Soft 68 Hospital Acquired Pneumonia 68 Patients Enrolled 68 Chronic Hepatitis B 68 ONGLYZA ™ 68 Am J Obstet 68 Injection Site 68 Proton Pump Inhibitor 68 METOZOLV TM ODT metoclopramide 68 Ovitrelle R Serostim 68 Patients Suffering 68 Benign Prostatic Hyperplasia 68 Antidepressant Drug 68 Identifies Potential 68 Sunesis Pharma 68 FDA Approves Drug 68 PEGylated anti 68 Metastatic Colorectal Cancer 68 Levels Linked 68 Lenocta TM 68 Glufosfamide 68 include Alferon N 68 memantine HCl 68 Completes Patient Enrolment 68 Preterm Labor 68 LEVADEX TM 68 please visit http:/www.vandapharma.com 68 Prophylactic Treatment 68 Acne Medication 68 Is Well Tolerated 68 Backs FY# Outlook 68 Fluconazole 68 developing Bicifadine serotonin 68 Treatment Naïve Patients 68 Application BLA 68 Indevus Pharma 68 Carbidopa Levodopa 68 Capsules CII 68 Ranolazine 68 Shown Effective 68 FDA Orphan Drug 68 Peginterferon 68 Gentium Announces 68 Reduced Risk 68 Acute Heart Failure 68 Coadministration 68 Fast Track Designation 68 oncolytic virus therapies 68 Demonstrate Significant 68 Systemic Sclerosis 68 Provides Guidance 68 Adjuvanted 68 Merck OSI Pharmaceuticals 68 Ridaforolimus 68 Patent Infringement Lawsuit Against 68 Reaffirms FY# Outlook 68 nanofiltered plasma derived 68 Golimumab 68 Relapsed Refractory 68 Oral Solution OSMOPREP 68 Files Voluntary 68 NOVARTIS 68 Phase III Clinical Trials 68 Interferon Alpha 68 Proves Effective 68 Receives Notification 68 Oxcarbazepine 68 DIURIL R 68 Regenerative Cells 68 Drug Application 68 Obtains CE Mark 68 Accelerated Approval 68 Novartis Novo Nordisk 68 Unsolicited Proposal 68 Million Doses 68 AnaSpec Introduces 68 Pediatric Patients 68 Drug Prevents 68 investigational oral inhibitor 68 Fast Track designations 68 Hepatitis C Treatment 68 Regains NASDAQ 68 selective A2A adenosine receptor 68 Silodosin 68 Clinical Outcome 68 Cethromycin 68 Oral Interferon 68 cardiometabolic diseases Glucophage 68 R MSCRAMM 68 Velaglucerase Alfa 68 Interferon beta 1a 68 Invasive Fungal Infections 68 Receives SFDA Approval 68 Announces Favorable 68 Oracea TM 68 pan histone deacetylase 68 Therapy Reduces 68 FDA Warns Against 68 PharmaVitae Profile 68 Roche Boniva 68 Transplant Patients 68 Disease Progression 68 Dose Escalation Study 68 Trobalt 68 Ofatumumab 68 Treatment Regimen 68 dextromethorphan quinidine 68 Allos Therapeutics Announces 68 Malaria Vaccine 68 NEBIDO VANTAS SUPPRELIN LA 68 Panzem R 68 Collaborators Publish 68 Provides Update Regarding 68 Influenza Virus Vaccine 68 Faropenem 68 Safinamide 68 Rotavirus Vaccines 68 Oral Suspension Oral Suspension 68 Randomized Phase 68 R roscovitine CDK cyclin 68 Lubiprostone 68 myelodysplastic myeloproliferative diseases 68 Randomized Trials 68 Lung Cancer Trial 68 Telaprevir VX 68 NASDAQ Listing Requirements 68 oral nucleoside analogue 68 CHMP Opinion 68 Advisers Urge 68 Flagship Product 68 Announces Presentation 68 developing Zerenex ferric 68 hydrochloride tablets 68 DIFICID ™ 68 Arthritis Drugs 68 TKB# 68 Prolongs Life 68 Atripla combines 68 testosterone gel LibiGel 68 Poniard Pharmaceuticals Announces 68 dual endothelin receptor antagonist 68 Marketing Authorization Application 68 Cholesterol Lowering 68 phenyl salicylate methylene blue 68 PEGylated Fab fragment 68 Subgroup Analysis 68 Fabry Disease 68 Disease IBD 68 Iloperidone 68 Cholesterol Drugs 68 Metabolic Efficiency 68 Montelukast 68 AAG geldanamycin analog 68 REPRONEX ® menotropins 68 candidates Azedra 68 Phospholipase A2 68 Inc. Nasdaq OXGN 68 successfully commercialize Iluvien 68 TNF Tumor Necrosis Factor 68 Transdermal Delivery 68 Ciclopirox 68 AUDIO PROVIDED BY 68 ® chorionic gonadotropin 68 nephropathic cystinosis cystinosis 68 Univest Corporation Declares 68 PPD Declares 68 Begins Shipment 68 dasatinib Sprycel ® 67 Files Patent Application 67 Voluntary Withdrawal 67 SIDE EFFECTS CHEAP ONLINE 67 Inflammatory Arthritis 67 POSIDUR TM ELADUR TM 67 Resubmit 67 Daptomycin 67 Surgical Adhesive 67 topical non steroidal 67 Influenza Vaccine Production 67 Corp. AMEX CVM 67 rasagiline tablets 67 Oral Suspension USP 67 Reports Positive 67 Enrolling Patients 67 Posaconazole 67 Biomarker Study 67 AVANIR Pharmaceuticals Announces 67 Patent Issued 67 Less Invasive 67 HYVISC ® treatment 67 ALN HPN 67 NGSX 67 DRRX 67 Desloratadine 67 Synthetic Peptide 67 Actonel risedronate 67 Granulocyte Colony Stimulating Factor 67 Clinical Evaluation 67 Entry Inhibitor 67 Tablet Formulation 67 #mg Tablets [002] 67 Initiate Phase II 67 Effective Than 67 Cocaine Addiction 67 Triaminic Infant & 67 Regeneron Pharma 67 sapropterin dihydrochloride Phase 67 Overactive Bladder 67 Announcement acc 67 LibiGel ® 67 Aliskiren 67 REPRONEX R menotropins 67 Study Shows Benefits 67 Topiramate Tablets 67 Paclitaxel Carboplatin 67 Vertex hepatitis C 67 Uracyst R Test 67 Javelin Pharma 67 HCl capsules 67 Key Milestones 67 Vaccine Shows Promise 67 SFDA Approval 67 Nasdaq XTLB 67 Miconazole 67 Glycopyrrolate 67 Dupuytren Contracture 67 Heart Stents 67 lexidronam injection 67 J Am Acad 67 Adjuvant Therapy 67 5q MDS 67 Pharma Merck Serono 67 Release Tablets 67 Successful Outcome 67 Placebo Controlled Trial 67 Reduces Pain 67 Gene Therapy Trial 67 Eluting Stent 67 topical antifungal product 67 Patients Undergoing 67 Orphan Drug Status 67 Barr Receives Approval 67 Acetate Rectal Suppositories 67 molecular imaging radiopharmaceutical 67 Tigecycline 67 Orally Disintegrating Tablets 67 investigational humanized monoclonal antibody 67 Adenoviral 67 Anti CD# Antibody 67 Announces License Agreement 67 Novel Treatments 67 Voluntarily Withdraws 67 Revises FY# Guidance 67 Arno Therapeutics 67 Pancreas Cancer Vaccine 67 Biological License Application 67 Ondansetron Injection USP 67 Treating Heart Failure 67 Postmenopausal Women 67 Vaccine Adjuvants 67 Obtains Approval 67 adalimumab Humira 67 Controlled Trial 67 Test Detects 67 Increased Mortality 67 IgG1 monoclonal antibody 67 Ltd Therapeutic Competitors 67 Wafer polifeprosan 67 Celgene Thalomid 67 erlotinib Tarceva R 67 Endometrial Cancer 67 Muraglitazar 67 OTCBB FCSC 67 Emtriva Viread 67 FACTIVE ® 67 Gel repository corticotropin injection 67 MKC# MT 67 Issued Patent 67 Expands Scientific Advisory 67 Provides Shareholder 67 SUTENT ® 67 COLLABORATION WITH 67 Bristol Myers Squibb sanofi 67 CEPHALON 67 Toremifene 67 Pharmacyclics Announces 67 FDA Approves Expanded 67 Reduces Mortality 67 induced macular edema 67 Vascular Disrupting Agent 67 Adipose Derived Stem Cells 67 Osteoporosis Drugs 67 Issues Guidance 67 Methylnaltrexone 67 Patent Infringement Suit Against 67 Dose Ranging 67 oral dual endothelin 67 FDA Cracks Down 67 interferon gamma 1b 67 Ecallantide 67 Inflammatory Markers 67 Stem Cell Treatment 67 Recurrent Breast Cancer 67 ORLive Presents 67 Regains Full 67 Breast Cancer Treatment 67 Improve Survival 67 Ciclesonide 67 Pulmonary Arterial Hypertension 67 Oral Insulin 67 Regulatory Clearance 67 Live Attenuated 67 Inhaled Liposomal Ciprofloxacin 67 Vaginal Gel 67 Develops Novel 67 Aurora Kinase 67 Mometasone Furoate 67 Conditional Approval 67 Backs FY# View 67 HIV treatments Reyataz 67 Zegerid OTC 67 MBRX 67 Rat Poison Found 67 Patent Lawsuit 67 Pain Medications 67 Sodium Injection 67 abacavir sulfate lamivudine 67 Medicure Announces 67 Announces Licensing Agreement 67 benzoic acid hyoscyamine sulfate 67 Intravitreal 67 GTC NASDAQ GTCB 67 Irinotecan 67 Non Invasive Treatment 67 Zidovudine Tablets 67 ABLYNX 67 Non Invasive 67 Serostim ® 67 Liver Toxicity 67 BioDelivery Sciences 67 Seliciclib CYC# 67 Friedreich Ataxia FRDA 67 Withdraws Application 67 Alexion Pharma 67 CHEAP ONLINE PHARMACY BEST 67 Panflu TM Sinovac 67 Elagolix 67 LymphoStat B TM 67 Luveris R Ovidrel R 67 Vitro Activity 67 Advancing Drugs 67 Renal Impairment 67 Drug Eluting Coronary Stent 67 Receives Clearance 67 Anticoagulant 67 Pirfenidone 67 Study Shows Promise 67 Successfully Treats